No Data
No Data
China Shineway Pharmaceutical Group Limited's (HKG:2877) Most Bullish Insider Is Top Key Executive Zhenjiang Li, and Their Holdings Value Went up by 9.0% Last Week
Key Insights Significant insider control over China Shineway Pharmaceutical Group implies vested interests in company growth 72% of the company is held by a single shareholder (Zhenjiang Li) Owner
China Shineway Pharmaceutical Group's (HKG:2877) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth
China Shineway Pharmaceutical Group Limited (HKG:2877) shareholders have seen the share price descend 10% over the month. But that doesn't change the fact that the returns over the last five years
Beizi Technology (603082.SH): Signed 125 million yuan logistics equipment procurement, installation and integration contract with Shenwei Pharmaceutical for modern warehousing and logistics projects
Gelonghui, May 29丨Beizi Technology (603082.SH) announced that the company recently signed the “Procurement, Installation and Integration Contract of Logistics Equipment for the Modern Warehousing and Logistics Project of Shenwei Pharmaceutical Group Co., Ltd.” with a total contract price of RMB 125 million.
SHINEWAY PHARM: Annual report 2023
Is Now The Time To Put China Shineway Pharmaceutical Group (HKG:2877) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the
SHINEWAY PHARM To Go Ex-Dividend On April 29th, 2024 With 0.461 HKD Dividend Per Share
March 30th - $SHINEWAY PHARM(02877.HK)$ is trading ex-dividend on April 29th, 2024. Shareholders of record on April 30th, 2024 will receive 0.461 HKD dividend per share on May 17th, 2024. The ex-d
No Data